Hyperfine Inc (HYPR) News

Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

Form 424B5 - Prospectus [Rule 424(b)(5)]

Hyperfine Announces $6.0 Million Registered Direct Offering

Hyperfine, Inc. (Nasdaq: HYPR) (“Hyperfine” or the “Company”) today announced it has entered into a definitive agreement with investors for the...

Form 8-K - Current report

Hyperfine Reports on Growing Evidence for the Use of Swoop® System Images in Stroke Diagnosis Presented at the 2025 International Stroke Conference

Two presentations at ISC build on a growing body of data demonstrating the value of AI-powered portable MR...

Form 8-K - Current report

Hyperfine Expands Global Market Reach with New Distribution Partnerships in European and Middle Eastern Markets

Strategic agreements set the stage for further global adoption of portable MR brain imaging technology...

Hyperfine Announces Extensive Clinical Study Coverage at RSNA 2024, Showcasing the Body of Evidence Supporting the Use of the Swoop® System Across Different Sites of Care

Eleven clinical studies presented at RSNA 2024 highlighted the growing clinician experience with the Swoop®...

Hyperfine Announces Strategic Leadership Additions to Drive Growth in Key Business Verticals

Two new executive roles position Hyperfine to drive the adoption of the Swoop® system in hospital settings and...

Hyperfine Swoop® Portable MR Brain Imaging System Meets New Standards Recently Issued by CMS-Approved Accrediting Body

Intersocietal Accreditation Commission (IAC)’s release of new standards accepting ultra-low-field MRI...

Hyperfine Announces Ten Abstracts at RSNA, Highlighting the Expanding Utility and Potential of Portable MR Brain Imaging in Diverse Clinical and Research Settings

The breadth of data being presented at the premier radiology meeting of 2024 illustrates the increasing...

Form 4 - Statement of changes in beneficial ownership of securities

Hyperfine, Inc. to Participate in Upcoming Investor Conferences

Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable...